Tissue immune response in epithelial ovarian carcinoma von Henriksen, Jon, Donskov, Frede, Waldstrøm, Marianne, Hjortkjær, Mette, Petersen, Christina Braad, Thomsen, Caroline Brenner, Jakobsen, Anders Kristian Moeller, Steffensen, Karina Dahl

Volltext

Veliparib and topotecan for patients with platinum-resistant or partially platinum-sensitive relapse of epithelial ovarian cancer with BRCA negative or unknown BRCA status von Hjortkjær, Mette, Kanstrup, Hanne, Jakobsen, Anders, Steffensen, Karina Dahl

Volltext

Favorable prognostic impact of Natural Killer cells and T cells in high-grade serous ovarian carcinoma von Henriksen, Jon Røikjaer, Donskov, Frede, Waldstrøm, Marianne, Jakobsen, Anders, Hjortkjaer, Mette, Petersen, Christina Braad, Dahl Steffensen, Karina

Volltext

Experiences with basic body awareness therapy as an add-on to cognitive behavioural therapy among Danish military veterans with PTSD: An interview study von Andersen, Mette Reitz, Clausen, Alex, Sternhagen Nielsen, Anni Brit, Hjort Svendsen, Ann Louise

Volltext

Forgiving Others: Pastoral Care of Forgiveness in Post-Secular Societies von Christoffersen, Mikkel Gabriel

Volltext

Bioengineered adipose-derived stem cells for targeted enzyme-prodrug therapy of ovarian cancer intraperitoneal metastasis von Malekshah, Obeid M., Sarkar, Siddik, Nomani, Alireza, Patel, Niket, Javidian, Parisa, Goedken, Michael, Polunas, Marianne, Louro, Pedro, Hatefi, Arash

Volltext

Choosing wisely: Selecting PARP inhibitor combinations to promote anti-tumor immune responses beyond BRCA mutations von Veneris, Jennifer Taylor, Matulonis, Ursula A., Liu, Joyce F., Konstantinopoulos, Panagiotis A.

Volltext

Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach von Boussios, Stergios, Karihtala, Peeter, Moschetta, Michele, Abson, Charlotte, Karathanasi, Afroditi, Zakynthinakis-Kyriakou, Nikolaos, Ryan, Jake Edward, Sheriff, Matin, Rassy, Elie, Pavlidis, Nicholas

Volltext

Delta tocotrienol in recurrent ovarian cancer. A phase II trial von Thomsen, Caroline Brenner, Andersen, Rikke Fredslund, Steffensen, Karina Dahl, Adimi, Parvin, Jakobsen, Anders

Volltext

Perspectives on PARP Inhibitor Combinations for Ovarian Cancer von Bonadio, Renata Colombo, Estevez-Diz, Maria Del Pilar

Volltext

Veliparib for the treatment of solid malignancies von George, Rony R, Thomas, Rimisha, Davice, Anna, Mathew, Meby S

Volltext

Being and Becoming among Young People Revealed through the Experience of COVID-19 von Andersen, Aida Hougaard, Viftrup, Dorte T., Bank, Mads

Volltext

An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective von Cordani, Nicoletta, Bianchi, Tommaso, Ammoni, Luca Carlofrancesco, Cortinovis, Diego Luigi, Cazzaniga, Marina Elena, Lissoni, Andrea Alberto, Landoni, Fabio, Canova, Stefania

Volltext

Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer von Jiang, Xuan, Li, Weihua, Li, Xiaoying, Bai, Huimin, Zhang, Zhenyu

Volltext

Combined inhibition of BADSer99 phosphorylation and PARP ablates models of recurrent ovarian carcinoma von Zhang, Xi, Wang, Liqiong, Chen, Shu, Huang, Peng, Ma, Lan, Ding, Hui, Basappa, Basappa, Zhu, Tao, Lobie, Peter E., Pandey, Vijay

Volltext

Veliparib: a new therapeutic option in ovarian cancer? von Ghisoni, Eleonora, Giannone, Gaia, Tuninetti, Valentina, Genta, Sofia, Scotto, Giulia, Aglietta, Massimo, Sangiolo, Dario, Mittica, Gloria, Valabrega, Giorgio

Volltext

Nordic obstetrics and gynecology theses July‐December 2018

Volltext

Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis? von Boussios, Stergios, Moschetta, Michele, Karihtala, Peeter, Samartzis, Eleftherios P, Sheriff, Matin, Pappas-Gogos, George, Ozturk, Mehmet Akif, Uccello, Mario, Karathanasi, Afroditi, Tringos, Michail, Rassy, Elie, Pavlidis, Nicholas

Volltext

La CIN 2 merite-t-elle la même prise en charge que la CIN 3 ? von Carcopino, X., Muszynski, C., Mergui, J.-L., Gondry, J., Boubli, L.

Volltext